Literature DB >> 21204815

Will seizure control improve by switching from the modified Atkins diet to the traditional ketogenic diet?

Eric H Kossoff1, Jennifer L Bosarge, Maria J Miranda, Adelheid Wiemer-Kruel, Hoon Chul Kang, Heung Dong Kim.   

Abstract

It has been reported that children can maintain seizure control when the ketogenic diet (KD) is transitioned to the less-restrictive modified Atkins diet (MAD). What is unknown, however, is the likelihood of additional seizure control from a switch from the MAD to the KD. Retrospective information was obtained from 27 patients who made this dietary change from four different institutions. Ten (37%) patients had ≥10% additional seizure reduction with the KD over the MAD, of which five became seizure-free. The five children who did not improve on the MAD failed to improve when transitioned to the KD. A higher incidence of improvement with the KD occurred for those with myoclonic-astatic epilepsy (70% vs. 12% for all other etiologies, p = 0.004), including all who became seizure-free. These results suggest that the KD probably represents a "higher dose" of dietary therapy than the MAD, which may particularly benefit those with myoclonic-astatic epilepsy. Wiley Periodicals, Inc.
© 2010 International League Against Epilepsy.

Entities:  

Mesh:

Year:  2010        PMID: 21204815      PMCID: PMC4040500          DOI: 10.1111/j.1528-1167.2010.02774.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  12 in total

1.  Prospective study of the modified atkins diet in combination with a ketogenic liquid supplement during the initial month.

Authors:  Eric H Kossoff; Jennifer L Dorward; Zahava Turner; Paula L Pyzik
Journal:  J Child Neurol       Date:  2010-09-10       Impact factor: 1.987

2.  Leukoencephalopathy associated with a disturbance in the metabolism of polyols.

Authors:  M S van der Knaap; R A Wevers; E A Struys; N M Verhoeven; P J Pouwels; U F Engelke; W Feikema; J Valk; C Jakobs
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

3.  Efficacy of the ketogenic diet as a treatment option for epilepsy: meta-analysis.

Authors:  C Beth Henderson; Francis M Filloux; Stephen C Alder; Joseph L Lyon; Deirdre A Caplin
Journal:  J Child Neurol       Date:  2006-03       Impact factor: 1.987

4.  A randomized, crossover comparison of daily carbohydrate limits using the modified Atkins diet.

Authors:  Eric H Kossoff; Zahava Turner; Renee M Bluml; Paula L Pyzik; Eileen P G Vining
Journal:  Epilepsy Behav       Date:  2007-02-26       Impact factor: 2.937

5.  Treatment and long-term prognosis of myoclonic-astatic epilepsy of early childhood.

Authors:  H Oguni; T Tanaka; K Hayashi; M Funatsuka; M Sakauchi; S Shirakawa; M Osawa
Journal:  Neuropediatrics       Date:  2002-06       Impact factor: 1.947

Review 6.  The modified Atkins diet.

Authors:  Eric H Kossoff; Jennifer L Dorward
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

Review 7.  Ketogenic ratio, calories, and fluids: do they matter?

Authors:  Elaine C Wirrell
Journal:  Epilepsia       Date:  2008-11       Impact factor: 5.864

8.  A modified Atkins diet is effective for the treatment of intractable pediatric epilepsy.

Authors:  Eric H Kossoff; Jane R McGrogan; Renee M Bluml; Diana J Pillas; James E Rubenstein; Eileen P Vining
Journal:  Epilepsia       Date:  2006-02       Impact factor: 5.864

9.  Current treatment of myoclonic astatic epilepsy: clinical experience at the Children's Hospital of Philadelphia.

Authors:  Sudha Kilaru; A G Christina Bergqvist
Journal:  Epilepsia       Date:  2007-07-25       Impact factor: 5.864

10.  Efficacy of the Atkins diet as therapy for intractable epilepsy.

Authors:  Eric H Kossoff; Gregory L Krauss; Jane R McGrogan; John M Freeman
Journal:  Neurology       Date:  2003-12-23       Impact factor: 9.910

View more
  10 in total

Review 1.  Epigenetics and epilepsy prevention: The therapeutic potential of adenosine and metabolic therapies.

Authors:  Detlev Boison; Jong M Rho
Journal:  Neuropharmacology       Date:  2019-08-13       Impact factor: 5.250

Review 2.  Ketogenic diets: new advances for metabolism-based therapies.

Authors:  Eric H Kossoff; Adam L Hartman
Journal:  Curr Opin Neurol       Date:  2012-04       Impact factor: 5.710

Review 3.  Ketogenic diet, neuroprotection, and antiepileptogenesis.

Authors:  Madhuvika Murugan; Detlev Boison
Journal:  Epilepsy Res       Date:  2020-08-19       Impact factor: 3.045

4.  Glycemic modulation in neuro-oncology: experience and future directions using a modified Atkins diet for high-grade brain tumors.

Authors:  Roy E Strowd; Mackenzie C Cervenka; Bobbie J Henry; Eric H Kossoff; Adam L Hartman; Jaishri O Blakeley
Journal:  Neurooncol Pract       Date:  2015-05-26

Review 5.  Dietary Therapies: Emerging Paradigms in Therapy of Drug Resistant Epilepsy in Children : Based on 6th Dr. I. C. Verma Excellence in Research Award Oration.

Authors:  Sheffali Gulati
Journal:  Indian J Pediatr       Date:  2018-09-21       Impact factor: 1.967

Review 6.  Neurobiochemical mechanisms of a ketogenic diet in refractory epilepsy.

Authors:  Patricia Azevedo de Lima; Leticia Pereira de Brito Sampaio; Nágila Raquel Teixeira Damasceno
Journal:  Clinics (Sao Paulo)       Date:  2014-12       Impact factor: 2.365

7.  Efficacy of and patient compliance with a ketogenic diet in adults with intractable epilepsy: a meta-analysis.

Authors:  Fang Ye; Xiao-Jia Li; Wan-Lin Jiang; Hong-Bin Sun; Jie Liu
Journal:  J Clin Neurol       Date:  2015-01-02       Impact factor: 3.077

8.  Ketogenic Ratio Determines Metabolic Effects of Macronutrients and Prevents Interpretive Bias.

Authors:  Tanya Zilberter; Yuri Zilberter
Journal:  Front Nutr       Date:  2018-08-30

Review 9.  The modified atkins diet in refractory epilepsy.

Authors:  Suvasini Sharma; Puneet Jain
Journal:  Epilepsy Res Treat       Date:  2014-01-30

10.  Ketogenic parenteral nutrition in 17 pediatric patients with epilepsy.

Authors:  Anastasia Dressler; Nadja Haiden; Petra Trimmel-Schwahofer; Franz Benninger; Sharon Samueli; Gudrun Gröppel; Sina Spatzierer; Angelika Mühlebner; Klaus Abraham; Martha Feucht
Journal:  Epilepsia Open       Date:  2017-11-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.